PROCTER & GAMBLE Co (PG) · Oct 22, 2026 · Earnings
Beat — Core EPS $2.00 vs ~$1.88 consensus
P&G earnings beat muted Q1 expectations on stronger sales and EPS, while commodity costs and reinvestment pressure margins and full-year guidance stays intact.
P&G is executing its established playbook: grow a focused portfolio of everyday brands while using productivity savings to fund innovation and offset cost pressure. Its broader strategy emphasizes brand superiority, productivity, and selective portfolio moves, with Thorne adding a premium wellness platform to the Health Care portfolio.
The quarter beat a deliberately soft expectation. Net sales rose 4% to $23.276 billion, while organic sales also grew 4%, powered by 2.4% volume growth and favorable mix rather than foreign exchange. Core EPS reached $2.00, up 1% year over year, versus published expectations around $1.88 for core EPS and $22.8 billion for revenue. (Financial Highlights; Net Sales Drivers) 〔0〕
| Metric | Q1 FY27 | Q1 FY26 / expectation | Read |
|---|---|---|---|
| Net sales | $23.276B | $22.386B; ~$22.8B consensus | Above expectation (Financial Highlights) |
| Organic sales growth | 4.0% | 4.0% prior-year comparison | Solid underlying growth (Net Sales Drivers) |
| Core EPS | $2.00 | $1.99 prior year; ~$1.88 consensus | Clear beat (Non-GAAP Reconciliation) |
| GAAP diluted EPS | $1.97 | $1.95 prior year | Up 1% (Financial Highlights) |
| Operating margin | 25.5% | 26.2% prior year | Down 70 bps (Financial Highlights) |
| Core currency-neutral operating margin | 25.8% | 27.1% prior year | Down 130 bps (Non-GAAP Reconciliation) |
| Operating cash flow | $5.767B | $5.408B prior year | Improved (Cash Flow statement) |
The quality of growth was better than the headline suggested. Total volume increased 2.4%, with Fabric & Home Care up 4.3% and Baby, Feminine & Family Care up 2.3%; Beauty also delivered 2.2% volume growth. That matters because P&G is showing more than price-led sales growth, although Health Care volume fell 2.9% and Grooming volume declined 0.4%. (Net Sales Drivers) 〔1〕
Margins are the trade-off behind the beat. Core currency-neutral gross margin fell 150 basis points as higher commodity costs and product reinvestment outweighed productivity savings. Core currency-neutral operating margin fell 90 basis points, even after 250 basis points of gross productivity savings. In plain English, P&G is generating enough sales and cost savings to beat low expectations, but it is spending heavily to protect brands and absorb inflationary inputs. (Gross Margin and Operating Margin commentary)
Guidance was stable, not upgraded. P&G kept its organic sales outlook at 1% to 3%, diluted EPS growth at 1% to 5%, and core EPS growth from in line to 3%. It changed the all-in sales range to 2% to 4% because the Thorne acquisition began contributing on October 1, 2026; that deal was already known, so the update adds limited surprise. The company also quantified a $0.79-per-share fiscal-year headwind from commodities, interest expense, lower non-operating income, and foreign exchange. (Fiscal 2027 Guidance)
Cash generation remains a stabilizer, but not the main surprise. Operating cash flow increased to $5.8 billion and P&G returned $3.9 billion through dividends and repurchases, supporting the shareholder-return side of the story despite the margin squeeze. (Cash Flow statement)
Bottom line: This was a meaningful earnings beat because sales and volume were stronger than a weak expectation set, while full-year targets stayed intact. The caveat is that the beat came alongside materially lower margins, so the business is advancing its growth story without yet solving its cost and reinvestment pressure.
A buy-side analyst on every ticker — it reads every public company's filing the instant it drops and decodes it into plain English.
A buy-side analyst on every ticker — the whole market decoded the second it moves, before it's a headline. Free gives you a taste. Pro takes the cap off and opens the full read on every company.
by Signing in NOW, claim your FREE 14-day Pro trial!